URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Sonal Munsiff

Concepts (197)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Tuberculosis
34
1996
53
9.150
Why?
Antitubercular Agents
21
1997
27
5.240
Why?
Mycobacterium tuberculosis
25
1996
51
4.790
Why?
Tuberculosis, Multidrug-Resistant
12
1997
12
3.430
Why?
Tuberculosis, Pulmonary
12
1997
29
2.940
Why?
New York City
35
1997
73
2.450
Why?
Tuberculin Test
9
2002
17
2.010
Why?
AIDS-Related Opportunistic Infections
10
1997
61
1.470
Why?
Rifampin
7
1997
15
1.380
Why?
Contact Tracing
6
2002
10
1.360
Why?
Drug Resistance, Multiple, Bacterial
3
2002
24
1.180
Why?
Disease Outbreaks
4
2003
116
1.140
Why?
Drug Resistance, Bacterial
6
2001
47
1.070
Why?
Disease Notification
3
2002
5
1.060
Why?
HIV Infections
7
1998
573
1.000
Why?
Emigration and Immigration
5
2003
22
0.930
Why?
Antibiotics, Antitubercular
4
1997
5
0.910
Why?
Adult
33
1997
11345
0.840
Why?
Humans
56
1993
36400
0.830
Why?
Infectious Disease Transmission, Patient-to-Professional
1
2010
7
0.780
Why?
Isoniazid
6
2002
9
0.780
Why?
Intensive Care Units, Neonatal
1
2010
58
0.760
Why?
World Health Organization
3
2005
42
0.740
Why?
Male
37
1993
19713
0.720
Why?
Female
38
1993
19826
0.720
Why?
Adolescent
18
1997
4752
0.700
Why?
Nucleic Acid Amplification Techniques
1
2009
12
0.700
Why?
Middle Aged
27
1993
9877
0.700
Why?
Molecular Diagnostic Techniques
1
2009
11
0.690
Why?
Risk Factors
14
1997
2318
0.690
Why?
Patient Compliance
3
2002
171
0.620
Why?
Aged
21
1993
7272
0.600
Why?
Outcome and Process Assessment (Health Care)
2
2006
84
0.590
Why?
Directly Observed Therapy
2
2005
4
0.580
Why?
Cross Infection
5
1993
87
0.580
Why?
Child
13
2002
4086
0.560
Why?
Child, Preschool
10
2002
2612
0.540
Why?
Self Administration
1
2005
19
0.530
Why?
Quality Assurance, Health Care
1
2006
119
0.520
Why?
Treatment Refusal
1
2005
43
0.520
Why?
Public Health Administration
4
2002
21
0.520
Why?
Drug Monitoring
1
2004
36
0.500
Why?
Sputum
8
2002
57
0.500
Why?
Program Evaluation
4
2002
205
0.480
Why?
Health Plan Implementation
1
2003
21
0.470
Why?
Retrospective Studies
11
2001
2260
0.430
Why?
Multivariate Analysis
5
1997
531
0.390
Why?
Latent Tuberculosis
2
2009
2
0.390
Why?
Homeless Persons
3
2003
11
0.380
Why?
Laboratories
1
2000
24
0.380
Why?
DNA Fingerprinting
2
1997
10
0.350
Why?
Aged, 80 and over
7
1997
2513
0.340
Why?
DNA, Bacterial
4
1997
174
0.330
Why?
HIV Protease Inhibitors
1
1999
53
0.330
Why?
Young Adult
7
2008
1074
0.320
Why?
Oligonucleotide Array Sequence Analysis
1
2000
284
0.320
Why?
Treatment Outcome
7
2001
2623
0.320
Why?
False Positive Reactions
4
1997
85
0.310
Why?
HIV Seropositivity
2
2003
34
0.300
Why?
Urban Population
2
2007
167
0.300
Why?
Case Management
2
2006
23
0.290
Why?
Molecular Epidemiology
3
2002
11
0.260
Why?
Cluster Analysis
5
2002
88
0.260
Why?
Incidence
6
2001
679
0.250
Why?
Substance Abuse, Intravenous
3
1998
16
0.250
Why?
Genotype
6
2001
487
0.240
Why?
Health Personnel
2
2003
59
0.240
Why?
Polymorphism, Restriction Fragment Length
4
1997
37
0.230
Why?
Occupational Exposure
3
2003
112
0.230
Why?
Case-Control Studies
2
2005
618
0.220
Why?
Cohort Studies
4
2001
969
0.220
Why?
Time Factors
4
1998
3201
0.210
Why?
Substance-Related Disorders
2
2010
207
0.210
Why?
Sensitivity and Specificity
2
2000
905
0.210
Why?
Health Services Misuse
1
2010
10
0.190
Why?
Drug Resistance, Microbial
4
1993
119
0.190
Why?
Infectious Disease Transmission, Vertical
1
2010
47
0.190
Why?
Oxazolidinones
1
2010
2
0.180
Why?
Demography
1
2010
97
0.180
Why?
Rifabutin
2
2005
5
0.180
Why?
Acetamides
1
2010
33
0.180
Why?
Medication Adherence
1
2009
21
0.170
Why?
Pregnancy
3
2003
1962
0.170
Why?
Practice Guidelines as Topic
2
2007
304
0.160
Why?
Infant, Newborn
2
2006
1831
0.160
Why?
Hospitalization
1
2010
377
0.160
Why?
Prevalence
3
2003
541
0.160
Why?
Communication
1
2010
271
0.150
Why?
Communicable Disease Control
1
2007
28
0.150
Why?
Drug Administration Schedule
2
2005
369
0.150
Why?
AIDS Serodiagnosis
1
2007
9
0.150
Why?
Infant
4
2002
2249
0.150
Why?
Predictive Value of Tests
1
2009
601
0.150
Why?
Organizational Objectives
1
2006
27
0.150
Why?
Social Responsibility
1
2006
15
0.150
Why?
Counseling
1
2007
70
0.140
Why?
Public Sector
1
2006
4
0.140
Why?
BCG Vaccine
2
2003
23
0.140
Why?
Ethambutol
1
2006
1
0.140
Why?
Private Sector
1
2006
5
0.140
Why?
Reproducibility of Results
1
2010
884
0.140
Why?
DNA Transposable Elements
2
2001
44
0.140
Why?
Aza Compounds
1
2006
24
0.140
Why?
Program Development
1
2006
77
0.140
Why?
Urban Health
1
2006
57
0.140
Why?
United States
3
2006
2630
0.140
Why?
Skin
1
2008
381
0.140
Why?
Quinolines
1
2006
46
0.140
Why?
Acquired Immunodeficiency Syndrome
2
1996
188
0.130
Why?
Health Knowledge, Attitudes, Practice
2
2005
279
0.130
Why?
Socioeconomic Factors
2
2003
383
0.130
Why?
Pregnancy Complications, Infectious
1
2006
84
0.130
Why?
World Health
1
2005
62
0.130
Why?
Risk Assessment
2
2005
878
0.120
Why?
Microbial Sensitivity Tests
4
1993
170
0.120
Why?
Workplace
1
2003
21
0.120
Why?
CD4 Lymphocyte Count
3
1996
148
0.120
Why?
Schools
1
2003
40
0.120
Why?
Hospitals, Urban
1
2003
9
0.120
Why?
Community-Acquired Infections
1
2003
30
0.110
Why?
Residence Characteristics
1
2003
66
0.110
Why?
Regression Analysis
2
1998
524
0.110
Why?
Genetic Variation
1
2003
148
0.110
Why?
Database Management Systems
1
2002
12
0.110
Why?
Immunization Programs
1
2003
57
0.110
Why?
Referral and Consultation
3
2006
198
0.110
Why?
Serologic Tests
1
2002
23
0.110
Why?
Streptomycin
1
2001
8
0.100
Why?
Age Factors
1
2005
1121
0.100
Why?
Drug Users
2
2011
4
0.100
Why?
Drug Resistance, Multiple
2
1997
30
0.100
Why?
Equipment Contamination
1
2000
15
0.090
Why?
Prospective Studies
3
1997
1677
0.090
Why?
Mass Screening
1
2003
252
0.090
Why?
Specimen Handling
1
2000
72
0.090
Why?
Emigrants and Immigrants
2
2008
9
0.090
Why?
Drug Interactions
1
1999
186
0.080
Why?
HIV Seronegativity
1
1998
21
0.080
Why?
Confidence Intervals
1
1998
165
0.080
Why?
Ambulatory Care Facilities
2
2005
33
0.070
Why?
Data Interpretation, Statistical
1
1998
155
0.070
Why?
Proportional Hazards Models
1
1998
453
0.070
Why?
Odds Ratio
1
1998
304
0.070
Why?
Survival Rate
1
1998
619
0.070
Why?
Diagnostic Errors
1
1997
89
0.070
Why?
Disease Progression
1
1998
519
0.070
Why?
Anti-HIV Agents
2
2003
166
0.070
Why?
Virus Replication
1
1996
283
0.060
Why?
Bacterial Typing Techniques
2
2001
24
0.060
Why?
Tuberculin
2
1996
4
0.060
Why?
Cost-Benefit Analysis
2
2003
209
0.060
Why?
Enterococcus
1
1993
7
0.060
Why?
Gram-Positive Bacterial Infections
1
1993
17
0.060
Why?
Vancomycin
1
1993
30
0.060
Why?
Comorbidity
2
2003
374
0.060
Why?
Community-Institutional Relations
1
2011
29
0.050
Why?
Recurrence
2
2001
697
0.050
Why?
HIV-1
1
1996
538
0.050
Why?
Gastrointestinal Diseases
1
2010
36
0.050
Why?
Bone Marrow Diseases
1
2010
44
0.050
Why?
Sex Factors
1
2011
584
0.040
Why?
African Americans
1
2010
214
0.040
Why?
Nervous System Diseases
1
2010
147
0.040
Why?
Databases, Factual
1
2008
151
0.040
Why?
Capreomycin
1
2007
1
0.040
Why?
Drug Administration Routes
1
2007
10
0.040
Why?
Radiography, Thoracic
1
2007
62
0.040
Why?
Africa
1
2006
9
0.040
Why?
Feasibility Studies
1
2007
205
0.040
Why?
Follow-Up Studies
1
2011
1857
0.030
Why?
Patient Education as Topic
1
2007
219
0.030
Why?
Prenatal Care
1
2006
70
0.030
Why?
Population Surveillance
1
2006
137
0.030
Why?
Drug Therapy, Combination
1
2006
390
0.030
Why?
Treatment Failure
1
2005
130
0.030
Why?
Occupational Diseases
1
2005
84
0.030
Why?
Masks
1
2003
7
0.030
Why?
Methadone
1
2003
17
0.030
Why?
Infection Control
1
2003
22
0.030
Why?
Pyrazinamide
1
2003
2
0.030
Why?
Developing Countries
1
2003
41
0.030
Why?
HIV
1
2003
82
0.030
Why?
Clinical Trials as Topic
1
2007
675
0.030
Why?
Interviews as Topic
1
2003
181
0.030
Why?
Physician's Practice Patterns
1
2006
253
0.030
Why?
Health Care Costs
1
2003
112
0.030
Why?
New York
1
2005
1282
0.020
Why?
Breast Feeding
1
2003
179
0.020
Why?
Bacteriological Techniques
1
1997
32
0.020
Why?
Cell Death
1
1996
174
0.020
Why?
Survivors
1
1997
114
0.020
Why?
Lymphocytes
1
1996
274
0.020
Why?
CD8-Positive T-Lymphocytes
1
1996
221
0.020
Why?
Enterococcus faecalis
1
1993
22
0.010
Why?
DNA Probes
1
1993
88
0.010
Why?
Base Sequence
1
1993
1704
0.010
Why?
Molecular Sequence Data
1
1993
2028
0.010
Why?

Visualizations


Munsiff's Networks

Concepts
_
Similar People
_
Same Department